LATE-STAGE DEVELOPMENT OF A PIKFYVE ANTISENSE OLIGONUCLEOTIDE TREATMENT FOR FTD

$4,167,674FY2025Defense Health AgencyDOD

Acurastem Incorporated

Investigators

View source on USAspending →